UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000019436
Receipt No. R000022471
Scientific Title Randomized Phase 2 study of Nintedanib and Pirfenidone versus Nintedanib following a clinically meaningful decline in forced vital capacity in patients with idiopathic pulmonary fibrosis administering pirfenidone
Date of disclosure of the study information 2015/10/21
Last modified on 2018/10/27 10:34:43

No. Disposal Last modified on Item of update
1 Insert 2015/10/21 15:21:03
2 Update 2015/12/16 20:12:15 Public title
Acronym
3 Update 2016/04/20 08:48:59 Primary outcomes
Primary outcomes
Key secondary outcomes
Key secondary outcomes
4 Update 2016/04/20 08:51:43 Key inclusion criteria
Key inclusion criteria
5 Update 2016/04/20 08:54:16 Name of primary sponsor
Department
Organization
Organization
6 Update 2016/04/20 08:55:16 Recruitment status
7 Update 2018/01/17 06:46:20 Recruitment status
8 Update 2018/10/27 09:43:53 Key inclusion criteria
Key inclusion criteria
Key exclusion criteria
Key exclusion criteria
9 Update 2018/10/27 10:34:43 Recruitment status
Anticipated trial start date


Contact us.